Comparación de fidaxomicina en posología convencional frente a fidaxomicina en posología extendida en pulsos en pacientes con alto riesgo de recurrencia de infección por C.difficile. Estudio multicéntrico mediante análisis de propensión”.

Dades bàsiques

Protocol:
235/22
EURDRACT:
NCT:
Centre:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:
2023
Any de finalització:
ESTUDIO OBSERVACIONAL

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

JAVIER COBO REINOSO

Resultats de l'Assaig Clínic


A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.

Santos JR; (...); Paredes R

Article. 10.1093/ofid/ofad542. 2023

  • Open Access.

Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.

Tenorio CH; (...); Vallecillos CG

Article. 10.1016/j.ijantimicag.2024.107164. 2024

  • Open Access.

Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023

Rodriguez-Leal, Cristobal M.; (...); Salavert, Miguel

Review. 10.37201/req/018.2024. 2024

  • Open Access.

Circulating extracellular vesicles in sera of chronic patients as a method for determining active parasitism in Chagas disease

Lozano, Noelia; (...); Osuna, Antonio

Article. 10.1371/journal.pntd.0012356. 2024

  • Open Access.

CMV REACTIVATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FROM HLA-MATCHED AND HAPLOIDENTICAL DONORS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE.

Chorão P; (...); Sanz J

Article. 10.1016/j.jtct.2024.01.082. 2024

  • Open Access.

Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].

Monzó-Gallo P; (...); Garcia-Vidal C

Correction. 10.1016/j.ijid.2024.107188. 2024

  • Open Access.

Current approach to skin and soft tissue infections. Thinking about continuity of care.

Blanes Hernández R; (...); Salavert Lletí M

Article. 10.37201/req/s01.10.2023. 2023

  • Open Access.

Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study.

Morata Ruiz L; (...); Grossi PA

Article. 10.1016/j.jgar.2023.11.015. 2024

  • Open Access.

Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.

Cabanero-Navalon, Marta Dafne; (...); Carda-Dieguez, Miguel

Article. 10.1016/j.clim.2023.109796. 2023


Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.

Gutierrez, Felix; (...); Masia, Mar

Article. 10.1093/cid/ciae359. 2024


Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

Corona, Diana; (...); Rivero, Antonio

Article. 10.1016/j.ijantimicag.2023.107016. 2024

  • Open Access.

Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020

Lozano, Noelia; (...); Calabuig, Eva

Article. 10.1016/j.actatropica.2024.107458. 2024

  • Open Access.

How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

Fernandez-Ruiz, Mario; (...); Aguado, Jose Maria

Article. 10.1016/j.eimc.2024.06.003. 2024

  • Open Access.

How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.

Fernandez-Ruiz, Mario; (...); Abril, Vicente

Article. 10.1016/j.eimce.2024.07.001. 2024

  • Open Access.

Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)

Masia, M.; (...); Martinez, E.

Correction. 10.1186/s13063-023-07655-9. 2023

  • Open Access.

Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.

Mussini, Cristina; (...); van Wyk, Jean

Article. 10.1007/s10461-024-04490-0. 2024

  • Open Access.

Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.

Chorao, Pedro; (...); Sanz, Jaime

Article. 10.1016/j.jtct.2024.12.006. 2024

  • Open Access.

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.

Álvarez H; (...); Poveda E

Article. 10.3389/fimmu.2023.1257725. 2023

  • Open Access.

Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain

Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez

Article. 10.1016/j.eimc.2023.07.005. 2024

  • Open Access.

Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.

Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo

Article. 10.1016/j.eimce.2023.07.009. 2023


Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report

Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero

Editorial Material. 10.1016/j.eimc.2024.02.008. 2024

  • Open Access.

Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.

Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta

Case Reports. 10.1016/j.eimce.2024.04.004. 2024


Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.

Cabanero-Navalon MD; (...); Garcia-Bustos V

Article. 10.3390/biomedicines12102239. 2024

  • Open Access.

Long or complicated mpox in patients with uncontrolled HIV infection.

Corma-Gómez A; (...); Macías J

Article. 10.1002/jmv.29511. 2024

  • Open Access.

Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)

Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.

Correction. 10.1016/j.kint.2024.10.002. 2024

  • Open Access.

Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.

Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.

Article. 10.1016/j.kint.2024.04.010. 2024

  • Open Access.

Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.

Llibre, Josep M; (...); Alcantara, Felipe Rodriguez

Article. 10.1111/hiv.13650. 2024

  • Open Access.

Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).

Valencia ME; (...); González J

Article. 10.1016/j.eimce.2024.05.005. 2024


Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies

Javier Candel, Francisco; (...); Cuervo Pinto, Rafael

Review. 10.37201/req/023.2023. 2023

  • Open Access.

Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.

Monzo-Gallo, Patricia; (...); Garcia-Vidal, Carolina

Article. 10.1016/j.ijid.2024.107070. 2024

  • Open Access.

SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines

Esteve-Sanchez, Yoel; (...); Climent, Estela

Article. 10.1016/j.snb.2024.136378. 2024

  • Open Access.

SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.

Lopez-Palacios, Alba; (...); Climent, Estela

Article. 10.1016/j.snr.2025.100298. 2025


Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis

Podzamczer, D.; (...); Rivero, A.

Meeting Abstract. 2023


Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.

Podzamczer, Daniel; (...); Rivero, Antonio

Article. 10.1093/jac/dkad285. 2023


Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.

Candel, Francisco Javier; (...); Serrano, Leyre

Article. 10.3390/jcm12216864. 2023

  • Open Access.

Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.

Candel, Francisco Javier; (...); Zaragoza, Rafael

Article. 10.3390/jcm12206526. 2023

  • Open Access.

The Challenge of Treating Infections Caused by Metallo-ß-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.

Hidalgo-Tenorio C; (...); Martínez-Martínez L

Article. 10.1007/s40265-024-02102-8. 2024

  • Open Access.

The positioning of ceftobiprole in Staphylococcus aureus bacteremia.

Membrillo de Novales FJ; (...); Hidalgo-Tenorio C

Article. 10.1093/cid/ciae123. 2024

  • Open Access.

The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.

Candel, Francisco Javier; (...); Zaragoza, Rafael

Article. 10.1186/s13054-024-05224-3. 2024

  • Open Access.

Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.

Vinuela, Laura; (...); Garcia, Federico

Article. 10.1002/jmv.29287. 2023

  • Open Access.

Treatment and prevention of monkeypox

Calle-Prieto, Fernando de la; (...); , TERDDPUGDDIYGDDDDS

Review. 10.1016/j.eimc.2022.08.0010213-005X. 2023

  • Open Access.

Trends in imported infections among migrants and travellers to Spain: a decade of analysis through the +Redivi network (2012-2022).

Alkaissy Y; (...); Perez-Molina JA

Article. 10.1093/jtm/taae067. 2024

  • Open Access.

Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.

Lozano N; (...); Osuna A

Article. 10.1371/journal.pone.0282814. 2023

  • Open Access.

Compartir el projecte